Benzinga | Feb 19, 2021 07:17AM EST

Anavex Life Sciences To Participate In Precision In Clinical Trials Virtual Summit Feb. 24 At 3:35 p.m. EST

NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer's disease, Parkinson's disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that its President and Chief Executive Officer, Christopher U. Missling, PhD, will give a presentation titled, "Clinical Trials for Rare Diseases: Challenges and Opportunities", at the Precision in Clinical Trials Virtual Summit (West Coast) on Wednesday, February 24th at 3:35 p.m. EST (12:35 p.m. PST). The Precision in Clinical Trials Virtual Summit (West Coast) takes place Feb 24th- 25th 2021.